Study population (n) | Hyperuricemia (n) | Prevalence (%) | 95% CI | P | |
---|---|---|---|---|---|
Age (years), n and % | < 0.001 | ||||
35–44 | 5425 | 397 | 7.3 | 6.6–8 | |
45–54 | 3759 | 328 | 8.7 | 7.8–9.6 | |
55–64 | 2932 | 270 | 9.2 | 8.2–10.3 | |
65–74 | 1989 | 266 | 13.4 | 11.9–14.9 | |
75–101 | 513 | 70 | 13.6 | 10.7–16.6 | |
Gender, n and % | < 0.001 | ||||
Men | 6819 | 808 | 11.8 | 11.1–12.6 | |
Women | 7799 | 523 | 6.7 | 6.2–7.3 | |
Residence, n and % | < 0.001 | ||||
Rural | 7974 | 967 | 12.1 | 11.4–12.8 | |
Urban | 6644 | 364 | 5.5 | 4.9–6 | |
eGFR (ml/min/1.73 m2), n and % | < 0.001 | ||||
≥ 90 | 5007 | 151 | 3 | 2.5–3.5 | |
60–89 | 6787 | 747 | 11 | 10.3–11.8 | |
30–59 | 2217 | 404 | 18.2 | 16.6–19.8 | |
15–29 | 95 | 23 | 24.2 | 15.6–32.8 | |
< 15 | 512 | 6 | 1.2 | 0.2–2.1 | |
Ethnicity, n and % | < 0.001 | ||||
Han | 5757 | 884 | 15.4 | 14.4–16.3 | |
Uygur | 4767 | 220 | 4.6 | 4–5.2 | |
Kazakh | 4094 | 227 | 5.5 | 4.8–6.2 | |
Total | 14,618 | 1331 | 9.1 | 8.6–9.6 |